• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Endocrinology

Association of oral corticosteroid bursts with severe adverse events in children

byBipandeep AbbatandAlex Chan
April 30, 2021
in Endocrinology, Pediatrics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Among a large cohort of children in Taiwan, oral corticosteroids prescribed for <14 days were associated with an increased risk of gastrointestinal (GI) bleeds, sepsis, and pneumonia during the first month of therapy initiation.

Evidence level rating: 2 (Good)

Oral corticosteroids are commonly prescribed to children for various inflammatory conditions, including asthma, inflammatory bowel disease, and bronchitis. Though the adverse effects of long-term corticosteroid use have been thoroughly explored in scientific literature, the short-term risks of therapies are not as well characterized. In this population-based cohort study, data from medical claims records and prescription data from the National Health Insurance Research Database from January, 2013 to December, 2017 was used to further explore the adverse events and potential risks of corticosteroid bursts, defined as treatment courses of 14 or fewer days. 1,064,587 participants younger than 18 years who received one burst of corticosteroid therapy were included in this self-controlled case series. Each participant’s risk of severe adverse events within the pre-treatment period (5-90 days prior to initiation of therapy) was compared to the risk within each of the two post-treatment periods (5-30 days and 31-90 days after initiation of therapy). The adverse events examined were GI bleeds, sepsis, pneumonia, and glaucoma. The study calculated incident rate ratios (IRR) by comparing the incident rates of severe events within each post-treatment period to the incident rates of severe events in the reference period (pre-treatment). During the first post-treatment period (5-30 days after therapy), the IRR was 1.41 (95% CI, 1.27-1.57) for GI bleeds, 2.02 (95% CI, 1.55-2.64) for sepsis, 2.19 (95% CI, 2.13-2.25) for pneumonia, and 0.98 (95% CI, 0.85-1.13) for glaucoma. During the second post-treatment period (31-90 days after therapy), the IRR was 1.10 (95% CI, 1.02-1.19) for GI bleeds, 1.08 (95% CI, 0.88-1.32) for sepsis, 1.09 (95% CI, 1.07-1.11) for pneumonia, and 0.95 (95% CI, 0.85-1.06) for glaucoma. Overall, the study demonstrates that corticosteroid bursts prescribed to children are associated with a 1.4 to 2.2-fold increased risk of GI bleeds, sepsis, and pneumonia, and provides data to further inform shared decisioned making between practitioners and patients.

Click to read the study in JAMA Pediatrics

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Sanofi wins approval for first Bruton’s tyrosine kinase inhibitor in immune thrombocytopenia

2 Minute Medicine Rewind August 18, 2025

Overweight body habitus is associated with higher rates of relapse in children with acute lymphoblastic leukemia

Tags: pediatricssteroids
Previous Post

Tailored antiplatelet therapy improves outcomes in patients undergoing percutaneous coronary intervention

Next Post

#VisualAbstract GHSG HD14: Intensified chemotherapy regimen (BEACOPP+ABVD) improved progression-free survival without improving overall survival over long-term follow-up

RelatedReports

Long-term dual antiplatelet therapy does not increase mortality risk
Hematology

Sanofi wins approval for first Bruton’s tyrosine kinase inhibitor in immune thrombocytopenia

September 9, 2025
Few high school students, young adults get HIV testing
Weekly Rewinds

2 Minute Medicine Rewind August 18, 2025

August 24, 2025
Severe subtype of acute lymphoblastic leukemia susceptible to FDA-approved kinase inhibitors
Chronic Disease

Overweight body habitus is associated with higher rates of relapse in children with acute lymphoblastic leukemia

August 7, 2025
Large proportion of late preterm infants and older admitted to the NICU
Chronic Disease

Preterm infants have increased risk of psychological and physical health comorbidities at adulthood

July 31, 2025
Next Post
#VisualAbstract GHSG HD14: Intensified chemotherapy regimen (BEACOPP+ABVD) improved progression-free survival without improving overall survival over long-term follow-up

#VisualAbstract GHSG HD14: Intensified chemotherapy regimen (BEACOPP+ABVD) improved progression-free survival without improving overall survival over long-term follow-up

Quick Take: Risk of rhabdomyolysis with donepezil compared with rivastigmine or galantamine

Non-drug interventions highly efficacious at reducing depressive symptoms in people with dementia

2 Minute Medicine Rewind May 3, 2021

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Artificial intelligence stethoscope detects heart disease in seconds
  • Comparative outcomes of laparoscopic lateral suspension, sacrocolpopexy, and transvaginal mesh for advanced apical prolapse: A retrospective cohort study
  • Semaglutide and tirzepatide may be cost-effective for knee osteoarthritis in patients with obesity
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.